Back to Top

Information For Authors

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

Manuscripts must be submitted using the following URL:

Please read all the instructions to authors before submitting.

LGBT Health is a peer-reviewed journal dedicated to promoting optimal healthcare for sexual and gender minority persons worldwide by identifying best practices and removing barriers to care.  While focusing narrowly on LGBT health, the Journal maintains sufficient breadth to encompass the full range of biopsychosocial and health policy matters relevant to each sexual and gender minority population under the LGBT umbrella.  The Journal provides a much-needed authoritative source and international forum in all areas pertinent to LGBT health and healthcare services. Contributions from all continents are solicited including regions which are currently underrepresented in sexual and gender minority research.

LGBT Health publishes original research, reviews, clinical reports, and perspectives in all of the areas identified above, as well select book reviews and letters to the editor.


Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same form or substantially similar form, except in the form of an abstract.  Presentation of an abstract at a meeting/conference should be disclosed in a footnote on the title page of the manuscript, and must include the name of the conference, meeting location, and date(s).

Special Open Access publishing option -- Contact:


All articles are peer-reviewed unless otherwise noted.  Submissions should not exceed the limits for text, figures/tables, and references listed below.

Original Articles

Original Articles present original quantitative or qualitative basic science, clinical, or psychosocial research.

Original Articles should include the following components:

  • Title page
  • Structured Abstract: Purpose; Methods; Results; Conclusion (250 word limit).
  • Text: Introduction; Methods; Results; Discussion; Conclusion (3000 word limit).
  • References: Maximum of 100 references.
  • Figure Legends
  • Tables and Figures: A maximum of 8 total figures and/or tables is permitted.


Review Articles

Review articles systematically review and analyze recent literature in an area of particular salience to the health of any sexual or gender minority group.

Review articles should include the following components:

  • Title page
  • Abstract: Structured headings are not essential (250 word limit).
  • Text: Introduction; Methods; Results; Discussion; Conclusion (4500 word limit). Details on the study selection and inclusion process and on the participants in each selected study should be included.
  • References: Maximum of 250 references.
  • Figure Legends
  • Tables and Figures: A maximum of 10 total figures and/or tables is permitted.

Short Reports

Clinical reports, case series, particularly promising preliminary findings, or other research findings that are not suitable for a full Original Article.

Short Reports should include the following components:

  • Title Page
  • Abstract: Structured headings (Purpose; Methods; Results; Conclusion) are ONLY required for original research (100 word limit).
  • Text: An Introduction and a brief Conclusion are mandatory for all articles. If the report is presenting original research, Methods, Results, and a Discussion are also required (2000 word limit). Include a concise literature review and a brief overview of the study and sufficient details on the study's methods and analysis.
  • References: Maximum of 25 references.
  • Figure Legends
  • Tables and Figures: A maximum of 3 total figures and/or tables is permitted.



Perspectives present opinions and insights on a current topic, describe novel hypotheses, or consider controversial issues, including legal, policy, and ethical issues. These articles may provide critical commentary on recent advances and future directions and discuss implications for clinical practice or public health. The perspective and points in the article should be supported by relevant literature.

Perspectives should include the following components: 

  • Title page
  • Abstract: Structured headings are not required (100 word limit)
  • Text: Introduction and a Conclusion are mandatory (1500 word limit).
  • References: Maximum of 25 references.
  • Figure Legends
  • Tables and Figures: A maximum of 3 total figures and/or tables is permitted.

Book Reviews

Short reviews of particularly salient books in the field with direct bearing on LGBT health will be considered.  Limit 1,000 words.  No abstract, figures, or tables. Include book title being reviewed, author and/or editors, publisher information, ISBN number, and number of pages.

Letters to the Editor

Comments on recently published LGBT Health articles (not peer reviewed).

Letters to the Editor should include the following components:

  • Title Page: Include a short title related to, but distinct from, the published article being addressed; No running head or keywords.
  • Text: 500 word limit.
  • References: Maximum of 5 references, one of which must be the LGBT Health article being discussed.
  • Figure Legends
  • Tables and Figures: A maximum of 1 total figure and/or table may be included.

Special Note: The Editors may choose to invite the authors to submit a response to the Letter.


All manuscript files must be uploaded to Do not submit the manuscript or any of its components in PDF format. All authors on a submitted manuscript must have a Manuscript Central account.


To facilitate the peer review process, select 4-6 keywords from the drop-down list when submitting your manuscript.   

Suggested Reviewers
Authors are encouraged to suggest the names and emails of appropriate reviewers during Manuscript Central submission, though final selection of reviewers is at the discretion of the Editors.

Cover Letter
Please include a cover letter from the corresponding author. The cover letter should include the following:

  • A statement indicating that the article has not been previously published in any form
  • A statement confirming that the article is not under consideration nor in press elsewhere
  • Authors are encouraged to detail the significance and uniqueness of the work in a single paragraph


General Formatting and Style 

  • Use of English Language: All submissions must be in English. LGBT Health uses American-style English.
  • Plagiarism: All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected immediately.
  • Word limits: Word limits do not include the title page, headings, abstract, acknowledgments, disclaimer, author disclosure statement, references, figures, tables, or legends.
  • Font: Times New Roman or Arial in 12-point type
  • Abbreviations: Expand all abbreviations at first mention in the text
  • Page size: Letter size (8.5 x 11 inches)
  • Margins: 1 inch
  • Line and word spacing: Double-space all manuscript pages, including figure legends.

Title Page

The title (first) page of all manuscripts must contain the following information:

1.   Exact title (No proprietary names, trade names, or abbreviations should be within the article title)
2.   All participating authors should be listed on the manuscript at the time of submission.  Changes in authorship will not be permitted after acceptance of an article.
3.   For each author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary        degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s), including department, institution, city, and state
  • Email address


            Group authors (i.e., “…on behalf of the XYZ Study”) are permitted

Co-first authors are also permitted. On the title page, please put an asterisk after each co-first author and note them as such.

    4.  For the Corresponding author provide:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s) including department name
  • Full mailing address, city, state, and country
  • Phone and fax numbers
  • Email address

5.    Running head: 50 characters or fewer (including spaces; abbreviations acceptable)

6.    Keywords: Provide a list of 4-6 keywords. These keywords will be included in the published article.

7.    Word Count/ Number of items: Indicate abstract and main text word counts and number of tables, figures, and appendices (if applicable).


Abstract (must be included within the main article file)

The abstract should appear on a separate page after the title page.   


  • Do not use proprietary or trade names
  • References are not permitted in the abstract
  • Headings do not contribute toward abstract word count


After the Conclusion of the main body of the manuscript, include a separate section acknowledging any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript. Also include acknowledgments of research support for the study.

After the Acknowledgments section, include a “Disclaimer” section, if needed, for the following: 

  • Detail any important disclaimers (for example, the primary data collection organization for a secondary-analysis article)
  • Provide all appropriate details if any part of the manuscript was presented previously


Author Disclosure Statement(s)

Following the Acknowledgments section (or Disclaimer if one was included), include a section entitled ‘‘Author Disclosure Statement.’’ Here authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals for further guidance. If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’




Study Design and Ethics

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.

Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.

Definitions of Scientific Misconduct

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  •  Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.

  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.

  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.

  • Material failure to comply with legislative and regulatory requirements affecting research:
    Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.

  • Conflict of Interest:  Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.

  • Simultaneous Submission:  Submitting a paper to more than one publication at the same time constitutes misconduct.

Responding to Allegations of Possible Misconduct

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation.  As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper.  In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record.  If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.


Protection of Research Participants

Informed Consent, Study Ethics Approval, and Subject Confidentiality

All manuscripts must comply with the recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. For more information, visit

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Helsinki Declaration as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.* In the Methods section of the article, authors must state that informed consent was obtained from subjects (specify written or verbal).

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, authors should provide assurance, and editors should so note, that such changes do not distort scientific meaning.*


When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed.*

*These sections of LGBT Health’s Instructions for Authors have been quoted directly from the International Committee of Medical Journal Editors website. For more information, visit

Authors are responsible for the accuracy and completeness of their references. Number references in the order they are cited in the text; do not alphabetize. In-text citations should be in sequential numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation.


  • Begin the Reference section on a separate page after the Author Disclosure Statement section
  • Double-space all lines and single-space between words
  • Articles accepted and in press are included in the Reference section
  • Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication
  • List all authors and/or editors if there are up to 4; for 5 or more, list the first 3 followed by et al.
  • For books, volume and edition numbers should be included when appropriate
  • Abbreviate journal names in accordance with PubMed / MEDLINE
  • Do not include PMIDs or PCMIDs
  • References that are abstracts should be indicated as such, with the abstract number included, if applicable
  • Please see below for specific LGBT Health format examples.

Reference Samples

Journal Article
Erchull MJ, Liss M: Clinical outcomes of enjoying sexualization among lesbian women. J Homosex 2015;62:340-352.

Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al.: Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009;94:3132-3154.

Chapter in edited volume
Pleak RR: Ethical issues in diagnosing and treating of gender-dysphoric children and adolescents. In: Sissies and Tomboys: Gender Nonconformity and Homosexual Childhood. Edited by Rottnek M. New York: New York University Press, 1999, pp 34-51.

Bagemihl B: Biological Exuberance: Animal Homosexuality and Natural Diversity, 1st ed. New York: St. Martin's Press, 1999.

Chapter in single authored book
Bagemihl B: The birds and the bees.  In:  Biological Exuberance: Animal Homosexuality and Natural Diversity, 1st ed. New York: St. Martin's Press, 1999, pp 9-42.

Resolution by professional association
American Medical Association House of Delegates. Resolution 122 (A-08). 122. 2008.

Task Force Report    
American Psychological Association Task Force on Gender Identity and Gender Variance. Report of the Task Force on Gender Identity and Gender Variance.  2009. Washington, DC, American Psychological Association.

Independent publisher
Consortium on the management of disorders of sex development: Handbook for Parents Rohnert Park, CA., Intersex Society of North America, 2006.

Publication by an association
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. DSM-IV-TR ed. Washington, DC, 2000.



Centers for Disease Control and Prevention. HIV/AIDS among men who have sex with men. 2007. Available at Accessed June 12, 2015.


Within the text, cite tables in the order in which they appear using Arabic numerals. Tables in accepted articles will be typeset and placed near the first mention of the table in the text; do not include separate lines indicating table placement.

Table guidelines:

  • Prepare all tables in one separate Word file.  Do not include them in the main article file and do not embed them in the text where they are cited.
  • Provide a brief but descriptive title for each table. Avoid abbreviations in the table title when possible
  • Table footnote(s) should include any essential notes and must include definitions of all abbreviations and acronyms used in the table


Within the text, cite figures in the order in which they appear using Arabic numerals. Figures in accepted articles will be typeset and placed near the first mention of the figure in the text; do not include separate lines indicating figure placement.

Figure guidelines: 

  • Figures include graphs, charts, diagrams, illustrations, and photographic images
  • All figures must be submitted as separate picture files.  Do not embed figures in the main article Word file.
  • Do not submit figures as PDFs, PowerPoint, or Excel files
  • To ensure proper print quality, please submit only TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process
  • Line illustrations should be submitted at 900 DPI.  Halftones and color should be submitted at a minimum of 300 DPI
  • Color art must be saved as CYMK, not RGB. (Note: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur)
  • Figure legends:

After the Reference section of the article in the main Word document include a separate page with the following information for each figure:
- A brief but descriptive title for each figure. Avoid abbreviations in the figure title when possible
- Define all relevant information in figures, including figure part labels, footnotes, abbreviations,    acronyms, arrows, and levels of magnification in insets

Online-Only Materials
Appendices and other supplementary materials should be included only when they are pertinent to the submitted manuscript but beyond the word or table/figure limits.  NOTE:  Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)

Appendix and supplementary material guidelines:

  • Published only with the online version of an accepted article
  • The print version of the article will include a URL directing readers to the online-only materials
  • Should be important to understanding or interpretation of the manuscript and limited in length
  • Should be original and not previously published
  • Acceptance of online-only materials is separate from acceptance of the manuscript and at the Editors’ discretion
  • Authors are encouraged to contact the Editor prior to submission of online-only materials


Post-Submission Information

Submission-Related Emails and Online Status
The Manuscript Central system sends emails only to the corresponding author (except for copyright release emails for accepted articles). Submitted manuscripts will show in the Manuscript Central Author Center of only the corresponding author.

Manuscript Decisions
Manuscripts may receive decisions of Reject, Major Revision, Minor Revision,  or Accept. A manuscript decision of Major Revision or Minor Revision does not guarantee the manuscript will ultimately be accepted. Article type word limits apply to revisions as well as initial submissions. A manuscript with a decision of Accept with Edits will not receive a formal Accept decision until all requested edits are satisfactorily completed.

It is the submitting author’s responsibility to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon submission. Once an article is accepted for publication, changes in authorship while the article is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.



Authors are responsible for procuring permissions to reproduce illustrations or tables taken from other publications and must be acknowledged by a complete credit line in the figure legend. The original publisher’s letter of permission should be available for submission to LGBT Health if requested by the Editors or the Publisher. A full citation should also be included in the Reference section.


Page Proofs

An email containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned within 3 business days to the Publisher with the author’s/authors’ approval or corrections.



Reprints may be ordered by following the special instructions that accompany page proofs and should be ordered at the time the corresponding author returns the corrected page proofs. Reprints ordered after an issue is printed will be charged at a substantially higher rate.



LGBT Health is published eight (8) times a year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; Email:;  Website:

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events